From the Journals

Reassurance for women taking certolizumab during pregnancy

Publish date: April 6, 2018

 

FROM ARTHRITIS & RHEUMATOLOGY


The study was funded by UCB Pharma. One author was a contractor for, and three were employees of, UCB Pharma. Six authors declared grants, consulting fees, and other remuneration from pharmaceutical companies, including UCB Pharma.

SOURCE: Clowse MEB et al. Arthritis & Rheumatology. 2018 Apr 5. doi: 10.1002/art.40508.

Pages

Recommended Reading

Experts bust common sports medicine myths
MDedge Rheumatology
Study sheds light on pregnancy outcomes following ocrelizumab treatment
MDedge Rheumatology
VIDEO: Biologic use during pregnancy had no impact on serious infection risks in infants
MDedge Rheumatology
Leflunomide use in pregnancy shows little impact on newborns
MDedge Rheumatology
Hydroxychloroquine use rising in SLE pregnancies
MDedge Rheumatology
Get ready for certolizumab for psoriasis
MDedge Rheumatology
Maternal biologic therapy does not affect infant vaccine responses
MDedge Rheumatology
FDA approves certolizumab label update for pregnancy, breastfeeding
MDedge Rheumatology
Axial SpA disease activity remains mostly stable throughout pregnancy
MDedge Rheumatology
MDedge Daily News: Why most heart failure may be preventable
MDedge Rheumatology